Axitinib-d3
Axitinib-d3
CAS: 1126623-89-9
Molecular Formula: C22H18N4OS
Axitinib-d3 - Names and Identifiers
| Name | Axitinib-d3 |
| Synonyms | Axitinib-d3 AG 013736-d3 [2H3]-Axitinib Axitinib-d3 H2O (N-methyl-d3) N-(Methyl-d3)-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzaMide |
| CAS | 1126623-89-9 |
Axitinib-d3 - Physico-chemical Properties
| Molecular Formula | C22H18N4OS |
| Molar Mass | 386.47 |
| Storage Condition | -20°C |
Axitinib-d3 - Introduction
Axitinib-d3(Axitinib-d3) is a deuterated axitinib, which belongs to a targeted inhibitor. It is used in the treatment of renal cell carcinoma (RCC) and can inhibit tumor growth and angiogenesis.
The preparation method of Axitinib-d3 can be synthesized by deuteration reaction. The specific preparation method includes reacting Axitinib (Axitinib) with a deuterated reagent to convert a hydrogen atom into a deuterium atom, thereby generating Axitinib-d3.
When using the Axitinib-d3, you need to pay attention to its safety information. Similar to other drugs, Axitinib-d3 may have some adverse effects. Common adverse reactions include hypertension, diarrhea, nausea, fatigue and so on. Patients should be thoroughly evaluated before use and monitored during treatment. In addition, Axitinib-d3 may also interact with other drugs, which may affect their efficacy or produce adverse reactions. Therefore, before using the Axitinib-d3, the doctor should be informed about the existing use of the drug.
To summarize, Axitinib-d3 is a deuterated form of axitinib for the treatment of renal cell carcinoma. The preparation method is synthesized by deuterated reaction. It is necessary to pay attention to its safety information, including possible adverse reactions and drug interactions.
The preparation method of Axitinib-d3 can be synthesized by deuteration reaction. The specific preparation method includes reacting Axitinib (Axitinib) with a deuterated reagent to convert a hydrogen atom into a deuterium atom, thereby generating Axitinib-d3.
When using the Axitinib-d3, you need to pay attention to its safety information. Similar to other drugs, Axitinib-d3 may have some adverse effects. Common adverse reactions include hypertension, diarrhea, nausea, fatigue and so on. Patients should be thoroughly evaluated before use and monitored during treatment. In addition, Axitinib-d3 may also interact with other drugs, which may affect their efficacy or produce adverse reactions. Therefore, before using the Axitinib-d3, the doctor should be informed about the existing use of the drug.
To summarize, Axitinib-d3 is a deuterated form of axitinib for the treatment of renal cell carcinoma. The preparation method is synthesized by deuterated reaction. It is necessary to pay attention to its safety information, including possible adverse reactions and drug interactions.
Last Update：2024-04-09 21:32:49
Supplier List
Product Name: Axitinib-d3 Visit Supplier Webpage Request for quotation
CAS: 1126623-89-9
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
CAS: 1126623-89-9
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
Product Name: Axitinib-d3 Visit Supplier Webpage Request for quotation
CAS: 1126623-89-9
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
CAS: 1126623-89-9
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
View History